The value of the model for considering the cost-effectiveness of interventions for the treatment of major depressive disorder in Canada
KEY POINTS Related research finds that the use of pharmacogenomic testing to guide treatment for people with major depressive disorder (MDD) simultaneously saves costs and improves clinical outcomes, a rarity …